Rosemary Mazanet

971 total citations
29 papers, 741 citations indexed

About

Rosemary Mazanet is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rosemary Mazanet has authored 29 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Hematology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rosemary Mazanet's work include Hematopoietic Stem Cell Transplantation (8 papers), Neutropenia and Cancer Infections (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Rosemary Mazanet is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Neutropenia and Cancer Infections (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Rosemary Mazanet collaborates with scholars based in United States and United Kingdom. Rosemary Mazanet's co-authors include Gary N. Schwartz, Lois Ayash, Karen H. Antman, I Tepler, Catherine Wheeler, C Lynch, M Hunt, Clara Franzini‐Armstrong, Stephen Pap and AD Elias and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Rosemary Mazanet

28 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosemary Mazanet United States 12 433 293 187 141 71 29 741
Mark A. Arnesen United States 11 445 1.0× 231 0.8× 172 0.9× 235 1.7× 66 0.9× 12 1.2k
I Tepler United States 11 681 1.6× 332 1.1× 151 0.8× 217 1.5× 75 1.1× 19 1.1k
Sarah M. Larson United States 14 343 0.8× 262 0.9× 89 0.5× 180 1.3× 60 0.8× 74 749
Suriya Jeyapalan United States 13 262 0.6× 287 1.0× 263 1.4× 92 0.7× 74 1.0× 33 926
Jean Pierre Marolleau France 17 324 0.7× 263 0.9× 77 0.4× 198 1.4× 104 1.5× 53 977
Claire Dearden United Kingdom 9 197 0.5× 378 1.3× 113 0.6× 157 1.1× 32 0.5× 16 947
Jee Sook Hahn South Korea 19 531 1.2× 244 0.8× 109 0.6× 326 2.3× 59 0.8× 57 1.2k
Shingo Wakatsuki Japan 11 289 0.7× 203 0.7× 70 0.4× 213 1.5× 51 0.7× 29 657
Manfred Hensel Germany 21 490 1.1× 310 1.1× 149 0.8× 188 1.3× 64 0.9× 68 1.6k
Rüediger Liersch Germany 18 332 0.8× 182 0.6× 145 0.8× 438 3.1× 65 0.9× 33 942

Countries citing papers authored by Rosemary Mazanet

Since Specialization
Citations

This map shows the geographic impact of Rosemary Mazanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Mazanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Mazanet more than expected).

Fields of papers citing papers by Rosemary Mazanet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Mazanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Mazanet. The network helps show where Rosemary Mazanet may publish in the future.

Co-authorship network of co-authors of Rosemary Mazanet

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Mazanet. A scholar is included among the top collaborators of Rosemary Mazanet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Mazanet. Rosemary Mazanet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rust, Werner, et al.. (2025). SR-02, a Pancreatic Islet Replacement Therapy Transplanted to the Omentum. American Journal of Transplantation. 25(8). S224–S224.
2.
Snook, Adam E., Guido Ghilardi, Steven Yang, et al.. (2023). Senza5 TM CART5: An Autologous CD5-Deleted Anti-CD5 CART Product with Enhanced Anti-T-Cell Lymphoma Activity. Blood. 142(Supplement 1). 3462–3462. 1 indexed citations
3.
4.
Majerus, Elaine M., Kenneth I. Ataga, Elliott Vichinsky, et al.. (2014). NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial. Blood. 124(21). 2718–2718. 2 indexed citations
5.
Mazanet, Rosemary, et al.. (2003). The state of biopharmaceutical manufacturing. PubMed. 9. 285–302. 28 indexed citations
6.
Crawford, Jeffrey, Dianne Tomita, Rosemary Mazanet, John A. Glaspy, & Howard Ozer. (1999). Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy.. PubMed. 5(4). 187–93. 29 indexed citations
7.
Elias, Alby, Lois Ayash, Catherine Wheeler, et al.. (1995). Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.. PubMed. 15(3). 373–9. 32 indexed citations
8.
Morstyn, George, et al.. (1995). Section Review—Oncologic, Endocrine & Metabolic: Haematopoietic Growth Factors in Cancer Chemotherapy. Expert Opinion on Investigational Drugs. 4(6). 515–523. 1 indexed citations
9.
Churchill, W. H., Colin A. Sieff, Lawrence N. Shulman, et al.. (1995). The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high‐dose chemotherapy support. Transfusion. 35(10). 837–844. 7 indexed citations
10.
Elias, Anthony, C Wheeler, I Tepler, et al.. (1994). High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.. PubMed. 21(5 Suppl 12). 83–5. 4 indexed citations
11.
Licht, Jonathan D., Rosemary Mazanet, Patrick J. Loehrer, R Gonin, & Karen H. Antman. (1994). Phase IV trial of daily oral etoposide in the treatment of advanced soft-tissue sarcoma. Cancer Chemotherapy and Pharmacology. 34(1). 79–80. 13 indexed citations
12.
Ayash, Lois, Anthony Elias, Catherine Wheeler, et al.. (1994). Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.. Journal of Clinical Oncology. 12(1). 37–44. 117 indexed citations
13.
Ayash, Lois, Anthony Elias, M Hunt, et al.. (1994). Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. British Journal of Haematology. 87(1). 153–161. 22 indexed citations
14.
Elias, Anthony, Lois Ayash, I Tepler, et al.. (1993). The Use of G-CSF or GM-CSF Mobilized Peripheral Blood Progenitor Cells (PBPC) Alone or to Augment Marrow as Hematologic Support of Single or Multiple Cycle High-Dose Chemotherapy. Journal of Hematotherapy. 2(3). 377–382. 8 indexed citations
15.
Elias, Anthony, Lois Ayash, Arthur T. Skarin, et al.. (1993). High-Dose Combined Alkylating Agent Therapy With Autologous Stem Cell Support and Chest Radiotherapy for Limited Small-Cell Lung Cancer. CHEST Journal. 103(4). 433S–435S. 8 indexed citations
16.
Elias, Anthony, Lois Ayash, Emil Frei, et al.. (1993). Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 85(7). 559–566. 44 indexed citations
17.
Mazanet, Rosemary & Karen H. Antman. (1991). Sarcomas of soft tissue and bone. Cancer. 68(3). 463–473. 70 indexed citations
18.
Elias, Anthony, Rosemary Mazanet, C Wheeler, et al.. (1991). GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols. Breast Cancer Research and Treatment. 20(S1). S25–S29. 16 indexed citations
19.
Mazanet, Rosemary & Clara Franzini‐Armstrong. (1982). Scanning electron microscopy of pericytes in rat red muscle. Microvascular Research. 23(3). 361–369. 47 indexed citations
20.
Mazanet, Rosemary, et al.. (1982). Variability in the shapes of satellite cells in normal and injured frog sartorius muscle. Developmental Biology. 93(1). 22–27. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Arnesen Breakdown of academic impact, for papers by I Tepler Breakdown of academic impact, for papers by Sarah M. Larson Breakdown of academic impact, for papers by Suriya Jeyapalan Breakdown of academic impact, for papers by Jean Pierre Marolleau Breakdown of academic impact, for papers by Claire Dearden Breakdown of academic impact, for papers by Jee Sook Hahn Breakdown of academic impact, for papers by Shingo Wakatsuki Breakdown of academic impact, for papers by Manfred Hensel Breakdown of academic impact, for papers by Rüediger Liersch
Rankless by CCL
2026